Abstract
Eight years have elapsed since the First Annual Symposium of the Barrow Neurologic Institute. Several sessions at that symposium, which was also devoted to infectious diseases of the central nervous system, concerned slow viral infections of the central nervous system (CNS). Detailed attention was given to three major diseases of human and veterinary medicine caused by conventional viral agents: visna, subacute sclerosing panencephalitis, and progressive multifocal leukoencephalopathy. Since that symposium several additional subacute or chronic viral infections of the human CNS have been delineated and considerable progress has been made toward a more molecular understanding of the mechanisms which underlie some of these disorders. In this chapter we consider only those diseases which are caused by conventional viruses; that is, infectious agents whose genomes consist of nucleic acids which are replicated intracellularly utilizing host cellular synthetic machinery and which direct the synthesis of proteins necessary for their continued efficient transfer to other uninfected cells or hosts. Such a definition would exclude from consideration viriods, infectious agents of plants with very small ribonucleic acids (RNA) which lack any associated protein, and the physicochemically incompletely defined transmissible agents of the subacute spongiform encephalopathies of animals (scrapie) and man (kuru, Creutzfeldt-Jakob disease).5 The latter agents, recently refered to as prions, are discussed in detail in the next chapter.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Johnson, R.T. Slow infections of the nervous system and the subacute spongiform encephalitis. Adv. Neurol. 6:69–75, 1974.
Johnson, K.P., Byington, D.P. and Gaddis, L. Subacute sclerosing panence-phalitis. Adv. Neurol. 6: 77–86, 1974.
Weiner, L.P. and Narayan, O. Progressive multifocal leukoencephalopathy. Adv. Neurol. 6:87–92, 1974.
Diener T.O. Viroids: Structure and function. Science 205:859–866, 1979.
Gajdusek, D.C. Unconventional viruses and the origin and disappearance of kuru. Science 197:943–960, 1977.
Mease, P.J., Ochs, H.D. and Wedgewood, R.J. Successful treatment of echovirus meningoencephalitis and myositis-faciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia. N. Engl. J. Med. 304:1218–1281, 1981.
Weiner, L.S., Howell J.T., Langford, M.P., Stanton, G.J., Baron, S., Goldblum, R.M., Lord R.A. and Goldman A.S. Effect of specific antibodies on chronic echo virus type 5 encephalitis in a patient with hypogammaglobulin-emia. J. Infect. Dis. 140:858–863, 1979.
Davis, L.E., Bodian, D., Price, D., Butler, I.J., and Vickers, J.H. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N. Engl. J. Med. 297:241–245, 1977.
Webster, A.B.D., Tripp, J.H., Hayward, A.R., Dayan A D., Doshi, R., Macintyre, E.H. and Tyrrell, A.J. Echovirus encephalitis and myositis in primary immunoglobulin deficiency. Arch. Dis. Child. 53:33–37, 1978.
Wilfert, CM., Buckley R.H., Mokanakumar, T, Griffith, J.F., Katz, S.L., Whisnant, J.K., Eggleston, P.A., Moore, M., Treadwell, E., Oxman, M.N. and Rosen, F.S. Persistent and fatal central nervous system echovirus infections in patients with agammaglobulinemia. N. Engl. J. Med. 296:1485–1489, 1977.
Seay, A.R. and Wolinsky, J.S. Ross River virus-induced demyelination. I. Pathogenesis and histopathology. Ann. Neurol. in press, 1982.
Aicardi, J., Goutieres, F., Arsenio-Nunes, M.L., and Lebon, P. Acute measles encephalitis in children with immunodepression. Pediatrics 59:232–239, 1977.
Haltia, M., Paetau, A., Valieri, A., Erkkilä, H., Donner, M., Kaahinen, K. and Holström, T. Fatal measles encephalopathy with retinopathy during cytotoxic therapy. J. Neurol. Sci. 32:323–330, 1977.
Murphy, J.V. and Yunis, E.J. Encephalopathy following measles infection in children with chronic illness. J. Pediatr. 88:937–942, 1976.
Pullan, C.R., Noble, T.C., Scott, D.J., Wisniewski, K. and Gardner, P.S. Atypical measles infections in leukaemic children on immunosuppressive treatment. Br. Med. J. 1:1562–1565, 1976.
Roos, R.P., Graves, M.C., Wollmann, R.L., Chilcote, R.R. and Nixon, J. Immunologic and virologic studies of measles inclusion body encephalitis in an immunosuppressed host: the relationship to subacute sclerosing pan-encephalitis. Neurology 31:1263–1270, 1980.
Spalke, G. and Eschenbach, C. Infantile cortical measles inclusion body encephalitis during combined treatment of acute lymphoblastic leukemia. J. Neurol. 220:269–277, 1979.
Wolinsky, J.S., Swoveland, P., Johnson, K.P. and Baringer, J.R. Subacute measles encephalitis complicating Hodgkin’s disease in an adult. Ann. Neurol. 1:452–457, 1977.
Johnson, K.P., Feldman, E.G. and Byington, D.P. Effect of neonatal thymec-tomy on experimental subacute sclerosing panencephalitis in adult hamsters. Infect. Immun. 12:1464–1469, 1975.
Chou, S.M., Roos, R., Burrell, R., Gutmann, L., and Harley, J.B. Subacute focal adenovirus encephalitis J. Neuropathol. Exp. Neurol. 32:34–50,1973.
Roos, R., Chou, S.M., Rodgers, N.G., Basnight, M. and Gajdusek, D.C. Isolation of an adenovirus 32 strain from human brain in a case of subacute encephalitis. Proc Soc. Exp. Biol. Med. 139:636–640, 1972.
Dorfman, L.J. Cytomegalovirus encephalitis in adults. Neurology 23:136–144, 1973.
Wu, B.C., Dowling, J.N., Armstrong, J.A. and Ho, M. Enhancement of mouse cytomegalovirus infection during host-versus-graft reaction. Science 190:56–58, 1975.
Ho, M., Suwansirikul, S., Dowling, J.N., Youngblood, L.A. and Armstrong, J.A. The transplanted kidney as a source of cytomegalovirus infection. N. Engl. J. Med. 293:1109–1112, 1975.
Murray H.W., Knox, D.L., Green, W.R. and Susel, R.M. Cytomegalovirus retinitis in adults: a manifestation of disseminated viral infection. Am. J. Med. 63:574–583, 1977.
Astrom, K.E., Mancali, E.L., and Richardson, E.P. Progressive multifocal leukoencephalopathy: A hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkins disease. Brain 81:93–111, 1958.
Silverman, L. and Rubenstein, L.J. Electron microscopic observations on a case of progressive multifocal leukoenephalopathy. Acta Neuropathol. 5:215–224, 1965.
ZuRhein, G.M. and Chou, S. Particles resembling papovaviruses in human cerebral demyelinating disease. Science 148:1477–1479, 1965.
Richardson, E.P. Progressive multifocal leukoencephalopathy. N. Engl. J. Med. 265: 815–823, 1961.
Padgett, B.L., Walker, D.L., ZuRhein, G.M., Eckroade, R.J. and Dessel, B.H. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1:1257–1260, 1971.
Padgett, B.L. and Walker, D.L. New human papovaviruses. Prog. Med. Virol. 22:1–35, 1976.
Padgett, B.L. and Walker, D.L. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J. Infect. Dis. 127:467–470, 1973.
ZuRhein, G.M., Padgett, B.L., Walker, D.L., Chun, R.W.N., Horowitz, S.D. and Hong, R. Progressive multifocal leukoenephalopathy in a child with severe combined immunodeficiency. N. Engl. J. Med. 299:256–257, 1978.
Greenlee, J.E. Effect of host age on experimental K virus infection of mice Infect. Immun. 33:297–303, 1981.
Greenlee, J.E. Protracted K virus infection in suckling mice and its reactivation by immunosuppression. Fifth International Congress of Virology, Strass-bourg. 1981:118A.
Gardner, S.D. The new human papovaviruses: their nature and significance. Rec. Adv. Clin. Virol. 1:91–115, 1977.
Reddy V.B., Thimmappaya, B., Dhar, R., Subramanian, K.N., Zain, S., Pan, J., Ghosh, P.K., Celma, M.L. and Weissman, S.M. The genome of SV-40. Science 200:494–502, 1978.
Hedley-White, E.T., Smith, B.P., Tyler, H.R. and Peterson, W.P. Multifocal leukoencephalopathy with remission and five year survival. J. Neuropathol. Exp. Neurol. 25:107–116, 1966.
Dörries, K., Johnson, R.T., and ter Meulen, V. Detection of polyoma virus DNA in PML-brain tissue by (in situ) hybridization. J. Gen. Virol. 42:49–57, 1979.
Rand, K.H., Johnson, K.P., Rubinstein, L.J., Wolinsky, J.S., Penney, J.B., Walker, D.L., Padgett, B.L. and Merrigan, T.C. Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy. Use of urine cytology to assess response to treatment. Ann. Neurol. 1:458–462, 1977.
London, W.T., Houff, S.A., Madden, D.L., Fuccillo, D.A., Gravell, M., Wallen, W.C., Palmer, A.E. and Sever, J.L. Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus). Science 201:1246–1249, 1978.
Castaigne, P., Rondat, P., and Escourolle, R. Leucoencephalopathie mul-tifocale progressive et ‘gliomes’ multiples. Rev. Neurol. 130:379–392, 1974.
Willoughby E., Price, R.W., Padgett, B.L., Walker, D.L. and Dupont, B. Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus. Neurology 30:256–262, 1980.
Smith, C.R., Sima, A.A.F., Salit, I.E. and Gentili, F. Progressive multifocal leukoencephalopathy: failure of cytarabine therapy. Neurology 32:200–203, 1982.
Berger, R., Florent, G., and Just, M. Decrease in the lymphoproliferative response to varicella-zoster virus antigen with age. Infect. Immun. 32:24–27, 1981.
Dolin, R., Reichman, R.C., Mazur, M.H., and Whitley, R.J. Herpes zoster-varicella infections in immunosuppressed patients. Ann. Intern. Med. 89:375–388, 1978.
McKendall, R.R. and Klawans, H.L. Nervous system complications of varicella-zoster virus. In: Handbook of Clinical Neurology. Vol 34. Vinken, P.J. and Bruyn, G.W. eds. Amsterdam: North Holland, pp. 161–183, 1978.
Whitley, R.J., Ch’ien, L.T., Dolin, R., Galasso, G.J. and Alford, C.A. Aden-ine arabinoside therapy of herpes zoster in the immunocompromised N. Engl. J. Med. 294:1193–1199, 1976.
Gilbert, G.J. Herpes zoster ophthalmicus and delayed contralateral hemipar-esis: relationship of the syndrome to central nervous system granulomatous angiitis. JAMA 229:302–304, 1974.
Hilt, D.C., Buchholtz, D., Krumholz, A., Weiss, H., Gale, A. and Wolinsky J.S. Post-zoster ophthalmicus cerebral angiitis and contralateral hemipare-sis. Neurology, 198A, 1982.
MacKenzie, R.A., Forbes, G.S. and Karnes, W.E. Angiographic findings in herpes zoster arteritis. Ann. Neurol. 10:458–464, 1981.
Pratesi, R., Freemon, F.R., Lowry, J.L. Herpes zoster ophthalmicus with contralateral hemiplegia. Arch. Neurol. 34:640–641, 1977.
Linnemann, C.C. and Alvira, M.M. Pathogenesis of varicella-zoster angiitis in the CNS. Arch. Neurol. 37:239–240, 1980.
Schwartz, J.N., Cashwell, F., Hawkins, H.K. and Klintworth, G.K. Necrotiz-ing retinopathy with herpes zoster opthalmicus. Arch. Pathol. Lab. Med. 100: 386–391, 1976.
Horten, B., Price, R.W. and Jimenez, D. Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster. Ann. Neurol. 9:251–266, 1980.
McCormich, W.F., Rodnitzky, R.L., Schochet, S.S. and McKee, A.P. Varicella-zoster encephalomyelitis: a morphologic and virologic study. Arch. Neurol. 21:559–570, 1969.
Sigurdsson, B. Observations on three slow infections of sheep. Maedi. Para-tuberculosis. Rida, a chronic encephalitis of sheep with general remarks on infections, which develop slowly, and some of their special characteristics. Br. Vet. J. 110:255–270, 307-322, 341-354, 1954.
Crawford, T.B., Adams, D.S., Cheevers, W.P., and Cork, L.C. Chronic arthritis in goats caused by a retrovirus. Science 207:997–999, 1980.
Cork, L.C, and Narayan, O. The pathogenesis of viral leukoencephalitis-arthritis of goats: I. Persistent viral infection with progressive pathologic changes. Lab. Invest. 42:596–602, 1980.
Pétursson, G., Nathanson N., Georgsson, G., Pantich H. and Pálsson, P.A. Pathogenesis of visna. I. Sequential virologic, serologic and pathologie studies. Lab. Invest. 35:402–412, 1976.
Clements, J.E., Narayan, O., Griffin, D.E., and Johnson, R.T. The synthesis and structure of visna virus DNA. Virology 93:377–386, 1979.
Haase, A.T. The slow infection caused by visna virus. Cur. Top. Microbiol. Immunol. 72:101–156, 1975.
Haase, A.T. and Varmus, H.E. Demonstration of DNA provirus in the lytic growth of visna virus. Nature New Biol. 245:237–239, 1973.
Haase, A.T., Stowring, L., Narayan, O., Griffin, D., and Price, D. Slow persistent infection caused by visna virus. Science 195:175–177, 1977.
Narayan, O, Griffin, D.E. and Silverstein, A.M. Slow virus infection: replication and mechanisms of persistence of visna virus in sheep. J. Infect. Dis. 135:800–806, 1977.
Griffin, D.E., Narayan, O. and Adams, R.J. Early immune responses in visna, a slow viral disease of sheep. J. Infect. Dis 138:340–350, 1978.
Griffin, D.E., Narayan, O., Bukowski, J.F., Adams, R.J. and Cohen, S. The cerebrospinal fluid in visna, a slow viral disease of sheep. Ann. Neurol. 4:212–218, 1978.
Nathanson, N., Pantich, H., Pétursson, G. and Georgsson, G. Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions. Lab Invest. 35:444–451, 1976.
Narayan, O., Griffin, D.E. and Clements, J.E. Virus mutation during’ slow infection’: temporal development and characterization of mutants of visna virus recovered from sheep. J Gen. Virol. 41:343–352, 1978.
Clements, J.E., Narayan, O., Pedersen, F S., and Haseltine, W.A. Mutation as a mechanism for escape from immunosuppression: The visna virus example. Cold Spring Harbor Conference on Cellular Profileration 7:953–967, 1980.
Narayan, O., Clements, J.E., Griffin, D.E. and Wolinsky, J.S. Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus. Infect. Immun. 32:1045–1050, 1981.
Narayan O., Wolinsky, J.S., Clements, J.E., Strandberg J.D., Griffin, D.E. and Cork, L.C. Slow virus replication: the role of macrophages in the persistence and expression of visna virus in sheep and goats. J. Gen. Virol. 59:345–356, 1982.
Dawson, J.R. Cellular inclusions in cerebral lesions of lethargic encephalitis. Am. J. Pathol. 9:7–16, 1933.
Bouteille, M., Fontaine, C, Vedrenne, C, and Delarue, J. Sur un cas d’encéphalite subaigüe à inclusions. étude anatomo-clinque et ultrastructurale. Rev. Neurol. 223:454–458, 1965.
Connolly, J.H., Allen, I.V., Hurwitz, L.J., and Miller, J.H.D. Measles-virus antibody and antigen in subacute sclerosing panencephalitis. Lancet 2:542–544, 1967.
Freeman, J.M., Magoffin, R.L., Lennette, E.H. and Herndon, R.M. Additional evidence of the relation between subacute inclusion-body encephalitis and measles virus. Lancet 2:129–131, 1967.
Horta-Barbosa, L., Fuccillo, D.A., London, W.T., Jabbour, J.T., Zeman, W. and Sever J.L. Isolation of measles virus from brain cell cultures of two patients with subacute sclerosing panencephalitis. Proc. Soc. Exp. Biol. Med. 232:272–277, 1969.
Payne, F.E., Baublis, J.V. and Itabashi, H.H. Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephali-tis. N. Engl. J. Med. 282:585–589, 1969.
Tellez-Nagel, I. and Harter, D.H. Subacute sclerosing leukeoencephalitis: ultrastructure of intranuclear and intracytoplasmic inclusions. Science 254:899–901, 1966.
Detels, R., Brody, J.A., McNew, J., and Edgar, A.H. Further epidemiologi-cal studies of subacute sclerosing panencephalitis. Lancet 2:11–14, 1973.
Agnardsóttir, G. Subacute sclerosing panencephalitis. Rec. Adv. Clin. Virol. 2:21–49, 1977.
Risk, W.S., and Haddad, F.S. The variable natural history of SSPE. Arch. Neurol. 36:610–614, 1979.
Robertson, W.C., Clark, D.B. and Markesbery, W.R. Review of 38 cases of subacute sclerosing panencephalitis: Effect of amantadine on the natural course of the disease. Ann. Neurol. 8:422–425, 1980.
Silva, CA., Paula-Barbosa, M.M., Pereira, S. and Cruz, C. Two cases of rapidly progressive subacute sclerosing panencephalitis: neuropathological findings. Arch. Neurol. 38:109–113, 1981.
ter Meulen, V. and Hall, W.W. Slow virus infections of the nervous system: virological, immunological and pathogenetic considerations. J. Gen. Virol. 42:1–25, 1978.
Haddad, F.S., Risk, W.S. and Jabbour J.T. Subacute sclerosing panencephalitis in the middle east: report of 99 cases. Ann. Neurol. 1:211–217,1977.
Risk, W.S., Haddad, F.S., and Chemali, R. Substantial spontaneous improvement in subacute sclerosing panencephalitis: six cases from the middle east and review of the literature. Arch. Neurol. 35:494–502, 1978.
Mandelbaum, D.E., Hall, W.W., Paneth, N., Wolff, R.R. and De Vivo, D.C. SSPE, measles virus, and the matrix protein: report of a case with unusual immunochemical findings. Ann. Neurol. 10:351–354, 1981.
Tourtellotte, W.W., Ma, B.I., Brandes, D.B., Walsh, M.J. and Potvin, A.R. Quantification of de novo central nervous system IgG measles antibody synthesis in SSPE. Ann. Neurol. 9:551–556, 1981.
Manabe, Y., Ono, Y., Okuno, T., Ueda, T., Nakano, Y. and Akaishi, K. Serial CT scans in subacute sclerosing panencephalitis. Comput. Tomogr. 5:25–30, 1981.
Morgan, E.M. and Rapp, F. Measles virus and its associated diseases. Bact. Rev. 41:636–666, 1977.
Choppin, P.W., Richardson, CD., Merz D.C, Hall, W.W., and Scheid, A. The functions and inhibition of the membrane glycoproteins of paramyx-oviruses and myxoviruses and the role of the measles virus M protein in subacute sclerosing panencephalitis. J. Infect. Dis. 243:352–363, 1981.
Thorne, E.V., Dermott, E. Y-forms as possible intermediates in the replication of measles virus nucleocapsids. Nature 268:345–347, 1977.
Robbins, S.J. and Rapp, F. Evidence of antigenic variation in a persistent in vitro measles virus infection. In: The Replication of Negative Strand Viruses, Bishop, D.H.L. and Compans, R.W., eds. New York: Elsevier-North Holland, pp.589–594, 1981.
Rustigian, R., Winston, S.W. and Darlington, R.W. Variable infection of Vero cells and homologous interference after co-cultivation with HeLa cells with persistent defective infection by Edmonston measles virus. Infect. Immun. 23:775–786, 1979.
Younger, J.S. and Preble, O.T. Viral persistence: evolution of viral populations. In: Comprehensive Virology. (Vol. 16. Fraenkel-Conrat, H., Wagner, R.R.), eds. New York: Plenum Press, pp. 73–135, 1980.
Rentier, B., Claysmith, A., Bellini, W.J. and Dubois-Dalcq, M. Chronic measles virus infections of mouse nerve cells in vitro. In: The Replication of Negative Strand Viruses. Bishop, D.H.L., and Compans, R.W., eds. New York: Elsevier-North Holland, pp. 595–601, 1981.
Black, F.L. Measles. In: A.S. Evans, ed. Viral Infections of Humans. Epidemiology and Control. New York: Plenum Press, pp. 297–316, 1976.
Johnson, K.P., Wolinsky, J.S. and Ginsberg, A.H. Immune mediated syndromes of the nervous system related to virus infections. In: Vinken, P.J., Bruyn, G.W., eds. Handbook of Clinical Neurology. Vol. 34, Amsterdam: North Holland, pp. 331–341, 1978.
Johnson, R.T., Hirsch, R.L., Griffin, D.E., Wolinsky, J.S., Roedenbeck, S., deSoriano, I.L. and Vaisberg, A. Clinical and immunological studies of measles encephalitis. Ann. Neurol. 10:74A, 1981.
Norrby, E., Orvell, C, Vandvick, B. and Cherry, J.D. Antibodies against measles virus polypeptides in different disease conditions. Infect. Immun. 54:718–724, 1981.
Fujinami, R.S. and Oldstone, M.B.A. Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced an-tigenic modulation. J. Immunol. 125:78–85, 1980.
Feorino, P.M., Humphrey, D., Hochberg, F. and Chilicote, R. Mononucleo-sis-associated subacute sclerosing panencephalitis Lancet 2:530–532, 1975.
Derakhshan, I., Massoud, A., Foroozanfar, N., Nikibin, B., Lofti, J., Shakib, N., and Ala, F. Subacute sclerosing panencephalitis: Clinical and immunologic study of 23 patients. Neurology 31:177–180, 1981.
Dhib-Jalbut, S.S., Abdelnoor, A.M., and Haddad, F.S. Cellular and humoral immunity in subacute sclerosing panencephalitis. Infect. Immun. 33:34–42, 1981.
Lennette, E.H. Cellular immunity and SSPE: summary of the conference. Arch. Neurol. 32:489–493, 1975.
Ahmed, A., Strong, D.M., Sell, K.W., Thurman, G.B., Knudsen, R.C., Wis-tar, R., and Grace, W.R. Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis: I. Partial characterization. J. Exp. Med. 139:902–924, 1974.
Steele R.W., Fuccillo, D.A., Hensen, S.A., Vincent, M.M. and Bellanti, J.A. Specific inhibitory factors of cellular immunity in children with subacute sclerosing panencephalitis. J. Pediatr. 88:56–62, 1976.
Swick, H.M., Brooks, W.H., Roszman, T.L. and Caldwell, D. A heat-stable blocking factor in the plasma of patients with subacute sclerosing panencephalitis. Neurology 26:84–88, 1976.
Dayan, A.D. and Stokes, M.I. Immune complexes and visceral deposits of measles antigens in subacute sclerosing panencephalitis. Br. Med. J. 2:374–376, 1972.
Noronha, A.B.C., Antel, J.P., Roos, R.P. and Medof, M.E. Circulating immune complexes in neurologic disease. Neurology 32:1942–1047, 1981.
Theofilopoulos, A.N., Wilson, C.B. and Dixon, F.J. The raji cell radioimmune assay for detecting immune complexes in human sera. J. Clin. Invest. 57:169–182, 1976.
Ewan, P.W. and Lachmann, P.J. IgG synthesis within the brain in multiple sclerosis and subacute sclerosing panencephalitis. Clin. Exp. Immunol. 35:227–235, 1979.
Link, H., Panelius, M. and Salmi, A.A. Immunoglobulins and measles antibodies in subacute sclerosing panencephalitis: demonstration of synthesis of oligoclonal IgG with measles antibody activity within the central nervous system. Arch. Neurol. 28:23–30, 1973.
Vandvik, B. Immunopathological aspects in the pathogenesis of subacute sclerosing panencephalitis with special reference to the the significance of the immune response in the central nervous system. Ann. Clin Res. 5:308–315, 1973.
Vandvik B and Norrby, E. Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc. Natl. Acad. Sci. 70:1060–1063, 1973.
Hall, W.W., Lamb, R.A. and Choppin, P.W. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc. Natl. Acad. Sci. 76:2047–2051, 1979.
Trudgett, A., Bellini, W.J., Mingioli, E.S. and McFarlin, D.E. Antibodies to the structural polypeptides of measles virus following acute infection and SSPE. Clin. Exp. Immunol. 39:652–656, 1980.
Wechsler, S.L., Weiner, H. and Fields, B.N. Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. J. Immunol. 123:884–889, 1979.
Dubois-Dalcq, M. Pathology of measles virus infection of the nervous system: comparison with multiple sclerosis. Int. Reu. Exp. Pathol. 19:101–135, 1979.
Katz, M. and Koprowski, H. The significance of failure to isolate infectious viruses in cases of subacute sclerosing panencephalitis. Arch. Ges. Virusforsch. 47:390–393, 1973.
Horta-Barbosa, L., Hamilton, R., Wittig B., Fuccillo, D.A. and Sever, J.L. Subacute sclerosing panencephalitis. Isolation of suppressed measles virus from lymph node biopsies. Science 173:840–841, 1971.
Wrzos, H., Kulczycki, J., Laskowki, Z., Matacz, D. and Brzosko, W.J. Detection of measles virus antigen(s) in peripheral lymphocytes from patients with subacute sclerosing panencephalitis. Arch. Virol. 60:291–297, 1979.
Haase, A.T., Swoveland, P., Stowring, L., Ventura, P., Johnson, K.P., Norrby, E. and Gibbs, C. J. Measles virus genome in infections of the central nervous system. J. Infect. Dis. 144:154–160, 1981.
Haase, A.T., Ventura, P., Gibbs, C.J. and Tourtellotte, W.W. Measles virus nucleotide sequence: detection by hybridization in situ. Science 272:672–674, 1981.
Gorecki, M., Rozenblatt, S. Cloning of DNA complementary to the measles virus mRNA encoding nucleocapsid protein. Proc. Natl. Acad. Sci. 77:3686–3690, 1980.
Rima, B.K., Lappin, S.A., Roberts, M.W., and Martin, S.J. Comparison of the polypeptides of morbilli viruses. Fifth International Congress of Virology, Strassbourg, 401A, 1981.
Lin, F.H. and Thormar, H. Absence of the M protein in a cell-associated subacute sclerosing panencephalitis virus. Nature 285:490–482, 1980.
Hall, W.W. and Choppin, P.W. Evidence for lack of synthesis of the M polypeptide of measles virus in brain cells in subacute sclerosing panen-cephalitis. Virology 99:443–447, 1979.
Hall, W.W., Choppin, P.W. Measles-virus proteins in the brain tissue of patients with subacute sclerosing panencephalitis: absence of the M protein. N. Engl. J. Med. 304:1152–1155, 1981.
Oldstone, M.B.A., Holmstoen, J. and Welsh, R.M. Alterations of acetylcho-line enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus. J. Cell. Physiol. 97:459–472, 1977.
Byington, D.P., Castro, A.E., and Burnstein, T. Adaptation to hamsters of neurotropic measles virus from subacute sclerosing panencephalitis. Nature 225:554–555, 1970.
Byington, D.P., and Johnson, K.P. Experimental subacute sclerosing panencephalitis in the hamster: Correlation of age with chronic inclusion-cell encephalitis. J. Infect. Dis. 126:18–26, 1972.
Johnson, K.P., Norrby, E., Swoveland, P. and Carrigan, D.R. Experimental subacute sclerosing panencephalitis: selective disappearance of measles virus matrix protein from the central nervous system. J. Infect. Dis. 144:161–169, 1981.
Server A.C. and Wolinsky J.S. Approaches to antiviral therapy. In: Muscular Dystrophy Association Conference on Amyotrophic Lateral Sclerosis. Rowland L., ed. New York: Raven Press, pp. 519–545, 1982.
Haddad, F.S. and Risk, W.S. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study. Ann. Neurol. 7:185–188, 1980.
Silverberg, R., Brenner, T. and Abramsky, O. Inosiplex in the treatment of subacute sclerosing panencephalitis. Arch. Neurol. 36:374–375, 1979.
Streletz, L. J. and Cracco, J. The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE). Ann. Neurol. 1:183–184, 1977.
Modlin, J.E., Jabbour, J.T., Witte, J.J. and Halsey, N.A. Epideminolgic studies of measles, measles vaccine and subacute sclerosing panencephalitis. Pediatrics 59:505–512, 1977.
Townsend, J.J., Baringer, J.R., Wolinsky, J.S., Malamud, N., Mednick, J.P., Panitch, H.S., Scott, R.A.T., Oshiro, L.S. and Cremer, N.E. Progressive rubella panencephalitis. Late onset often congenital rubella. N. Engl. J. Med. 292:990–993, 1975.
Weil, M.L., Itabashi, H.H., Cremer, N.E., Oshiro, L.S., Lennette, E.H. and Camay, L. Chronic progressive panencephalitis due to rubella virus simulating subacute sclerosing panencephalitis. N. Engl. J. Med. 292:994–998, 1975.
Wolinsky, J.S. Progressive rubella panencephalitis. In: Vinken, P.J. and Bruyn, G.W., eds. Handbook of Clinical Neurology. Vol. 34. Amsterdam: North Holland, pp. 331–339, 1978.
Cremer, N.E., Oshiro, L.S., Weil, M.L., Lennette, E.H., Itabashi, H.H., and Camay, L. Isolation of rubella virus from brain in chronic progressive panencephalitis. J. Gen. Virol. 29:143–153, 1975.
Payment, P.D., Ajdukovic, D. and Povilanis, V. Le virus de la rubeole. I. Morphologic et proteines structurales. Can. J. Microbiol. 21:703–709,1975.
Vaheri, A. and Hovi, T. Structural protejns and subunits of rubella virus. J Virol. 9:10–16. 1972.
Waxham, M.N. and Wolinsky, J.S. Immunochemical identification of the hemagglutinin of rubella virus. Virology 126:194–203, 1983.
Väänänen, P. and Kääriäinen, L. Fusion and hemolysis of erythrocytes caused by three togaviruses: semliki forest, sindbis and rubella. J. Gen. Virol 46:467–475, 1979.
Rawls, W.E. Viral persistence in congenital rubella. Prog. Med. Virol. 18:273–288, 1974.
Williams, M.P., Brawner, T.A., Riggs, H.G. and Roehrig, J.T. Characteristics of a persistent rubella infection in a human cell line. J. Gen. Virol. 52:321–328, 1981.
Menser, M.A., Harley, J.D., Hertzberg, R., Dorman, D.C. and Murphy, A.M. Persistence of virus in lens for three years after prenatal rubella. Lancet 2:387–388, 1967.
Grahame, R., Armstrong, R., Simmons, N.A., Mims, C.A., Wilton, J.M.A. and Laurent, R. Isolation of rubella virus from synovial fluid in five cases of seronegative arthritis. Lancet 2:649–651, 1981.
Chantier, J.K., Ford, D.K., and Tingle, A.J. Rubella-associated arthritis: Rescue of rubella virus from peripheral blood lymphocytes two years post vaccination. Infect. Immun. 32:1274–1280, 1981.
Coyle, P.K., Wolinsky, J.S., Buimovici-Klein, E., Mocha, R., and Cooper, L.Z. Rubella specific immune complexes after congenital infection and vaccination. Infect. Immun. 36:498–503, 1982.
Wolinsky J.S., Dau, P.C., Buimovici-Klein, E., Mednick, J., Berg, B.O., Lang, P.B. and Cooper, L.Z. Progressive rubella panencephalitis: immun-ovirologic studies and results of isoprinosine therapy. Clin. Exp. Immunol. 35:394–404, 1979.
Coyle, P.K., and Wolinsky, J.S. Characterization of immune complexes in progressive rubella panencephalitis. Ann. Neurol. 9:557–562, 1981.
Vandvik, B., Weil, M.L., Grandien, M. and Norrby, E. Progressive rubella panencephalitis: synthesis of oligoclonal virus-specific IgG antibodies and homogenous free light chains in the central nervous system. Acta Neurol. Scand. 57:53–64, 1978.
Wolinsky, J.S., Waxham, M.N., Hess, J., Townsend, J.J. and Baringer, J.R. Immunochemical features of a case of progressive rubella panencephalitis. Clin. Exp. Immunol. 48:359–366, 1982.
Townsend, J.J., Stroop, W.G., Baringer, J.R., Wolinsky, J.S., McKerrow, K.H. and Berg, B.O. Neuropathology of progressive rubella panencephalitis after childhood rubella. Neurology 32:185–190, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Spectrum Publications, Inc.
About this chapter
Cite this chapter
Wolinsky, J.S. (1984). Slow Virus Infection by Conventional Virus Agents. In: Thompson, R.A., Green, J.R. (eds) Infectious Diseases of the Central Nervous System. Neurologic Illness. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6332-3_3
Download citation
DOI: https://doi.org/10.1007/978-94-011-6332-3_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-6334-7
Online ISBN: 978-94-011-6332-3
eBook Packages: Springer Book Archive